Hopetohelp's post about mutant allele % prompted me to share some good news. I was diagnosed with PV and JAK2 V617F in July 2021 after a heart attack caused by a blocked artery. At that point my mutant allele frequency was 60%. I started on hydroxyurea, but as it did nothing to relieve my severe itching, my hematologist moved me on to Jakafi/ruxolitinib. Itching ceased almost overnight.
I see my hematologist every 3 months now to monitor my counts. He has focused (rightly) on getting the counts as close as possible to normal to avoid future thrombosis. While that has been my interest too, I have also been interested to read on this forum about how interferons such as Besremi might actually help stop disease progression, whereas (as I understand it) Jakafi merely inhibits the gene from doing its bad stuff (halts rather than reverses progression). I asked if we could do another JAK2 mutant quantification test, given it has been 2 years since the first one. My thought was that if my % was broadly the same, I might ask again about trying Besremi, as 60% struck me as high.
Great news: I am now at 25% mutant allele frequency! Of course, I have no idea of Jakafi is responsible for this pretty dramatic reduction, but it seems likely, doesn't it? Keen to hear others' thoughts/experiences.